Ricevi le ultime notizie sulle azioni Vera Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di VERA

Ultime notizie per

VERA THERAPEUTICS INC

VERAMARK TECHS INC

Vera Therapeutics

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

RDNT

VERA

VKTX

Con un RSI inferiore a 30 e rating favorevoli da analisti di spicco, questi titoli del settore sanitario presentano un ottimo potenziale.

Titoli sanitari: 3 investimenti che potrebbero decollare questo trimestre

Vera Therapeutics, Inc. - Class A Common Stock

Vera Therapeutics Inc

Verastem Inc

Veralto Corp

VERANO HLDGS CORP by Verano Holdings Corp.

Verano Holdings Corp

Veracyte Inc

Veradigm Inc

Vera Bradley Inc

VERALLIA,COURBEVOIE by VERALLIA, COURBEVOIE

Verallia

Verasity

Contracts

Press Releases

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

General

Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial in Adults with IgA Nephropathy

Financing

Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans

Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Earnings

Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Health Care

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics to Participate at Upcoming Investor Conferences

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Celcuity

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Cogent Biosciences

Denali Therapeutics

Dyne Therapeutics

89bio

Galapagos NV - American Depositary Shares

Galapagos

GRAIL

IDEAYA Biosciences

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Mesoblast Limited - American Depositary Shares

Mesoblast

MannKind

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Novavax

Arcus Biosciences

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Stoke Therapeutics

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vericel

Viridian Therapeutics, Inc. - Common Stock

Comments

Vera Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO